Amantadine hydrochloride Renata 100 mg Capsules, hard Malta - English - Medicines Authority

amantadine hydrochloride renata 100 mg capsules, hard

renata pharmaceuticals (ireland) limited 13-18 city quay, dublin , dublin, d02ed70 , ireland - amantadine hydrochloride - hard capsule - amantadine hydrochloride 100 mg - anti-parkinson drugs

Amantadine hydrochloride Renata 100 mg Capsules, hard Ireland - English - HPRA (Health Products Regulatory Authority)

amantadine hydrochloride renata 100 mg capsules, hard

renata pharmaceuticals (ireland) limited - amantadine hydrochloride - capsule, hard - amantadine

Fludrocortisone Acetate Renata 0.1 mg tablets Malta - English - Medicines Authority

fludrocortisone acetate renata 0.1 mg tablets

renata pharmaceuticals (ireland) limited 13-18 city quay, dublin , dublin, d02ed70 , ireland - tablet - fludrocortisone acetate 0.1 mg - corticosteroids for systemic use

Fludrocortisone Acetate Renata 0.1 mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

fludrocortisone acetate renata 0.1 mg tablets

renata pharmaceuticals (ireland) limited - fludrocortisone acetate - tablet - fludrocortisone

METOPROLOL TARTRATE FILM COATED- metoprolol tartrate tablet United States - English - NLM (National Library of Medicine)

metoprolol tartrate film coated- metoprolol tartrate tablet

renata limited (general plant-2) - metoprolol tartrate (unii: w5s57y3a5l) (metoprolol - unii:geb06nhm23) - hypertension metoprolol tartrate tablets, usp are indicated for the treatment of hypertension. they may be used alone or in combination with other antihypertensive agents. angina pectoris metoprolol tartrate tablets, usp is indicated in the long-term treatment of angina pectoris. myocardial infarction metoprolol tartrate tablets, usp are indicated in the treatment of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality when used alone or in conjunction with intravenous metoprolol. oral metoprolol tartrate tablets, usp therapy can be initiated after intravenous metoprolol therapy or, alternatively, oral treatment can begin within 3 to 10 days of the acute event (see dosage and administration, contraindications , and  warnings ). hypertension and angina metoprolol tartrate tablets, usp are contraindicated in sinus bradycardia, heart block greater than first degree, cardiogenic shock, and overt cardiac failure (see warnings ). hypersensitivity

PRENATAL, DHA- thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, ascorbic acid, niacin, folic acid, fe United States - English - NLM (National Library of Medicine)

prenatal, dha- thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, ascorbic acid, niacin, folic acid, fe

puretek corporation - thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), niacin (unii: 2679mf687a) (niacin - unii:2679mf687a), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), ferrous fumarate (unii: r5l488ry0q) (ferrous c - thiamine 3 mg - prenatal + dha™ is indicated to provide vitamin/mineral and dha omega-3 fatty acid supplement to women throughout pregnancy, during the postnatal period for both lactating and non-lactating mothers, and throughout the childbearing years. prenatal + dha™ may be beneficial in improving the nutritional status of women prior to conception. this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

PRENATAL 19- .beta.-carotene, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine mononitrate, riboflavin, United States - English - NLM (National Library of Medicine)

prenatal 19- .beta.-carotene, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine mononitrate, riboflavin,

nationwide laboratories, llc - beta carotene (unii: 01yae03m7j) (beta carotene - unii:01yae03m7j), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), p - .beta.-carotene 1000 [iu] - prenatal 19 tablets are indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and non-lactating mothers. prenatal 19 tablets are also useful in improving the nutritional status of women prior to conception. this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

PRENATAL 19- folic acid, .beta.-carotene, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine mononitrate, United States - English - NLM (National Library of Medicine)

prenatal 19- folic acid, .beta.-carotene, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine mononitrate,

nationwide laboratories, llc - folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), beta carotene (unii: 01yae03m7j) (beta carotene - unii:01yae03m7j), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), nia - folic acid 1 mg - prenatal 19 chewable tablets are indicated for use in improving the nutritional status of women throughout pregnancy and in postnatal period for both lactating and non-lactating mothers. prenatal 19 chewable tablets are also useful in improving the nutritional status of women prior to conception. this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

PRENATAL PLUS- vitamin a acetate, beta carotene, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine monon United States - English - NLM (National Library of Medicine)

prenatal plus- vitamin a acetate, beta carotene, ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, dl-, thiamine monon

blenheim pharmacal, inc. - vitamin a acetate (unii: 3le3d9d6oy) (vitamin a - unii:81g40h8b0t), beta carotene (unii: 01yae03m7j) (vitamin a - unii:81g40h8b0t), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (alpha-tocopherol, dl- - unii:7qwa1rio01), thiamine mononitrate (unii: 8k0i04919x) (thiamine - unii:x66nso3n35), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacina - vitamin a 3080 [iu] - prenatal plus vitamin and mineral tablet is an tan-yellow colored, modified oval biconvex film coated tablet debossed g12 on one side, and provides 10 vitamins and 4 minerals to supplement the diet before, during and after pregnancy. each prenatal plus tablet contains: vitamin a (acetate and beta carotene) .......................................4000 i.u. vitamin c (ascorbic acid)……………………………………...........….120 mg vitamin d-3 (cholecalciferol)……………….....................................400 i.u. vitamin e (dl- alpha tocopheryl acetate)……………………...............22 mg thiamine (vitamin b-1 from thiamine mononitrate………............…1.84 mg riboflavin (vitamin b-2)………………………………………...............…3 mg niacin(niacinamide)……………………………………………………....  20 mg vitamin b-6 (pyridoxine hcl)…………………………………................10 mg folic acid……………………………………………………............……...1 mg vitamin b-12 (cyanocobalamin)……………………………................12 mcg calcium (calcium carbonate)……………………………….........…